Hyderabad, India, and Princeton, NJ, U.S.; 04th January, 2024:  Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced that it has acquired MenoLabs^®business, a leading women’s health and dietary supplement branded portfoliofrom Amyris, Inc. (“Amyris”)in Amyris’ Chapter 11 sales process.

Dr. Reddy’s acquired the entire MenoLabssupplementsportfoliowhich includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause. Brands includeMenoFit™ and MenoGlow™ probiotics, Happy Fiber™ and Well Rested™ dietary supplements, Athena’s Shield™ menopause support supplement, and Goodness Glow™ and Keep Glowing Gorgeous™supplements for healthy aging support. The deal also includes the MenoLife® health tracker app which supports the product line and provides community, education, and information to consumers regarding menopause. MenoLabs portfolio of products is sold in the United States, primarily through the brand’s own [https://menolabs.com] and other e-commerce marketplaces including Amazonand Walmart.

“The MenoLabs acquisition will serve as a catalyst to accelerate growth in this space and build upon our aspiration tolead in the fast-growing women’s nutritional and wellness markets,” says Marc Kikuchi, Chief Executive Officer for Dr. Reddy’s in North America. “The acquisition complements Dr. Reddy’s U.S.self-care and wellness business portfolio of brandsand addresses unmet needs of consumersfor science-based, research-driven products that provide relief from the symptoms of menopause. For these and many other reasons, I believe we are well-positioned tosuccessfully integrate and grow the business.”